-
Michael J. Fox Foundation Commits up to $10 Million for Pre-Clinical Drug Development Under Therapeutics Development Initiative
April 1, 2008
… to alleviate complications of current treatments such as dyskinesias (the disruptive movements that are a side effect …
-
The Michael J. Fox Foundation Awards $2.8 Million to Drive Development of Parkinson's Disease Biomarker Pipeline
February 4, 2010
… have been shown in pre-clinical models to reduce dyskinesias, the involuntary movements that are a … Role of Striatal Serotonergic Terminals in L-Dopa Induced-Dyskinesia in PD Patients Paola Piccini, MD, PhD, FRCP, …
-
Michael J. Fox Foundation Surpasses $50-Million Brin Wojcicki Challenge
February 27, 2013
… therapies, as well as treatments for cognition and dyskinesia, closer than ever to the clinic. Increasing the …
-
What We Fund: $10 Million in New Grants for Parkinson’s Research
June 20, 2019
… PhD, at Duke University is testing a new approach to stop dyskinesia, uncontrolled movements that come with long-term …
-
Research Perspective: The Growing Importance of Digital Disease Measures
June 30, 2020
… measures of health and function (e.g., heart rate, tremor, dyskinesia, gait, balance) throughout the day as well as …
-
What We Fund: $19 Million to Test New Treatments, Measure Mobility with Radio Signals, and Relate Environmental and Genetic Risk
October 27, 2021
… therapy to levodopa to ease motor symptoms and reduce dyskinesia . Approaches to Slow or Stop Parkinson’s Seven …